Historical record - last NADAC effective date: 7/22/2020
Product Information
TRAMADOL ER 300 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $3.6925 per EA under NDC 47335053783. Its NADAC has been published 399 times since Nov 28, 2013.
FDA first approved this application on Dec 30, 2011.
Strength
300 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335053783
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
7/22/2020
Active Ingredients
TRAMADOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091607FDA Approved
12/30/2011
On Market Since
12/30/2011
Pharmacological Classes
Price Statistics
The NADAC for TRAMADOL ER 300 MG TABLET has been published 399 times since Nov 28, 2013, and over the history we have for it it has declined 25.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.6925 per EA |
|---|---|
| All-time high | $6.3879 (Apr 15, 2015) |
| All-time low | $3.1934 (Nov 21, 2018) |
| Median price | $4.2672 |
| Average price | $4.2882 |
| Largest weekly change | +36.4% (Jan 20, 2016) |
| Weeks tracked | 399 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-25.9%
Last surveyed Jul 14, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 41% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
TRAMADOL HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRAMADOL ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRAMADOL ER 300 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $3.6925 per EA (NDC 47335053783), effective Jul 14, 2021.
How has the price of TRAMADOL ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRAMADOL ER 300 MG TABLET has declined 25.9%. It has been tracked across 399 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRAMADOL ER 300 MG TABLET?
Since Nov 28, 2013, the NADAC for TRAMADOL ER 300 MG TABLET has ranged from a low of $3.1934 (Nov 21, 2018) to a high of $6.3879 (Apr 15, 2015), with a median of $4.2672 per EA.
Are there cheaper alternatives to TRAMADOL ER 300 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRAMADOL HCL ER 300 MG TABLET, is $2.1604 per EA — about 41% below TRAMADOL ER 300 MG TABLET.
Who manufactures TRAMADOL ER 300 MG TABLET?
TRAMADOL ER 300 MG TABLET (NDC 47335053783) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.